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To clarify the potential for respiratory transmission of 
Saffold cardiovirus (SAFV) and characterize the pathogen, 
we analyzed respiratory specimens from 1,558 pediatric pa-
tients in Beijing. We detected SAFV in 7 (0.5%) patients and 
identiﬁ  ed lineages 1–3. However, because 3 patients had 
co-infections, we could not deﬁ  nitively say SAFV caused 
disease.
S
affold cardiovirus (SAFV) is a new piconavirus, origi-
nally identiﬁ  ed from fecal samples of a female infant 
with fever of unknown origin (1). SAFV has since been 
reported worldwide, and 8 lineages have been identi-
ﬁ  ed (1–6). Although serologic surveys have shown that 
SAFV-3 infection occurs early in life (7), the pathogenicity 
of SAFV is still unclear.
Because SAFVs are mainly detected in fecal samples, 
virus transmission is thought to occur by the fecal–oral 
route (1,3–7). However, 2 research groups also found 
SAFV-2 lineage in respiratory secretions (2,4). Thus, we 
investigated whether the respiratory tract route could be an 
additional transmission route and whether SAFV lineages 
other than SAFV-2 may also infect the respiratory tract. 
We identiﬁ  ed and characterized 7 SAFV strains, which be-
longed to 3 distinct lineages, from respiratory samples of 
children with lower and upper respiratory tract infections 
(LRTIs and URTIs, respectively).
The Study
We assessed 2 cohorts. Cohort 1 comprised 1,032 chil-
dren (617 boys and 415 girls) with acute LRTIs, hospital-
ized in Beijing Children’s Hospital (BCH), from whom 
nasopharyngeal aspirates were collected from May 2007 
through March 2009. The patients ranged in age from 
2 weeks to 16 years (mean age 31.3 months, median 9 
months). Cohort 2 comprised 506 BCH outpatient children 
(277 boys and 229 girls) with acute URTIs, from whom 
throat swabs were collected from May through August 
2009. These patients ranged in age from 4 months to 16 
years (mean age 46.7 months, median 37 months).
Virus nucleic acids in clinical samples were extracted 
by using the NucliSens easyMAG system (bioMérieux, 
Marcy-l’Etoile, France) according to the manufacturer’s 
instructions. SAFV RNA was detected by nested reverse 
transcription–PCR (RT-PCR) by using primers selective 
for the 5′ untranslated region (UTR) (3). The viral protein 
(VP) 1 gene was ampliﬁ  ed by using 3 pairs of primers as 
previously described (3,5,6). The full genomic sequences 
were obtained by a genome walking method (7). The 5′ and 
3′ UTR sequences were determined by using the RACE 
System (Invitrogen, Carlsbad, CA, USA) according to 
the manufacturer’s protocol. After being cloned into the 
pGEM-T Easy vector (Promega, Madison, WI, USA), all 
PCR products were veriﬁ  ed by sequencing. In addition, all 
screened specimens were tested for known respiratory vi-
ruses as previously described (8,9). Mycoplasma pneumo-
niae was detected by using the gelatin particle agglutina-
tion test kit (SERODIA-MYCO II, Fujirebio, Japan).
For phylogenetic analysis, we constructed neighbor-
joining trees based on the distances of SAFV nucleotide or 
amino acid sequences by using MEGA 4.0 (10). We used 
SimPlot (version 3.5.1) to analyze possible recombination 
between viral genome sequences (11).
LLC-MK2 cells were used to isolate SAFV as previ-
ously described (12). Cells were collected either when cy-
topathic effects were observed or after 12 days postinocula-
tion, and then they were tested for SAFV by RT-PCR.
We detected SAFV RNA in 4 (0.4%) of the 1,032 na-
sopharyngeal aspirates from patients with LRTIs and in 3 
(0.6%) of the 506 throat swab specimens from outpatients 
with URTIs. The SAFV-positive patients (4 girls and 3 
boys) were 5 months to 9 years of age (Table). SAFV in-
fection did not appear to have a predominant time for oc-
currence: cases were detected in a range of months for the 
periods covered (August and December 2007, October and 
November 2008, and June 2009). All SAFV-positive pa-
tients exhibited symptoms of respiratory tract infection, 
such as coughing, gasping, sneezing, or fever. Of the 4 
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Table. Characteristics of patients with Saffold cardiovirus, Beijing, China, 2007–2009* 
Patient












BCH350  5 mo/M  2007 Dec 7  Broncho- 
pneumonia 
Cough, gasping  Respiratory failure  RSV 3
BCH895  2 y, 8 mo/M  2008 Oct 6  Pneumonia  Fever, cough, spitting, 
gasping, chills 
No EV 1
BCH1031  4 y/M  2008 Nov 16  Peribronchitis Fever, cough, spitting, 
gasping, chills, sneezing 
No None 3
BCHU79  1 y, 6 mo/F  2009 Jun 5  URTI  Fever, cough  Unknown  None  2
BCHU115 1  y,  10 
mo/F
2009 Jun 6  URTI  Fever, cough  Unknown  None  3
BCHU353  4 y, 6 mo/F  2009 Jun 17  URTI  Fever, cough  Unknown  None  2
*SAFV, Saffold cardiovirus; RSV, respiratory syncytial virus; EV, enterovirus; URTI, upper respiratory tract infection. 
Figure 1. Phylogenetic analysis of Saffold cardiovirus (SAFV) strains obtained in Beijing, China, 2007–2009, based on viral protein (VP) 1 
(A), P1 capsid proteins (B), and full-length genomes (C). The trees, with 500 bootstrap replicates, were generated by using the neighbor-
joining algorithm in MEGA 4.0 (10). Strains identiﬁ  ed in this study are indicated by a speciﬁ  c identiﬁ  cation code (BCH or BCHU), followed 
by the patient number and labeled with dark triangles (BCH133, BCH350, BCH895, BCH1031, BCHU79, BCHU115, and BCHU353). 
GenBank accession nos. of the complete genome sequences are BCH1031 GU943513, BCHU115 GU943514, and BCHU79 GU943518; 
of the P1 gene, BCH350 GU943515, BCH895 GU943516, and BCHU353 GU943517; and of the VP1 gene of BCH133, GU126461. 
SAFV-1 (prototype), UC1-UC7, Can112051-06, D/VI2229/2004, BR/118/2006, D/VI2273/2004, D/VI2223/2004, LZ50419, GL317, Pak12, 
Pak971, Afg1449, Pak1141, Pak2578, Pak5003, Pak5152, Pak6572, and NL2007, TEMV-GDVII, Theiler-like virus NGS910, and Vilyuisk 
virus were used as reference sequences (GenBank accession nos. NC009448, NC010810, EU604745-EU604750, AM922293, EU681176-
EU681179, FJ586240, FJ464767, FJ463600-FJ463602, FJ463604, FJ463605, FJ463615-FJ463617, FM207487, X56019, AB090161, 
and EU723237). Scale bars incdicate nucleotide substitutions per site.SAFV-positive patients with LRTIs, 2 had underlying ill-
nesses, i.e., tuberculosis, hepatic dysfunction, or respiratory 
failure (Table). All SAFV-positive patients recovered with-
in 7–11 days. No major differences were found in disease 
duration between patients who had underlying diseases and 
those who did not.
Co-infections with additional respiratory pathogens 
were detected for 3 of 7 SAFV-positive patients, all in the 
ﬁ  rst cohort. These pathogens were respiratory syncytial vi-
rus (1 patient), enterovirus (1 patient), and M. pneumoniae 
(1 patient) (Table). A SAFV-3 strain was isolated from 
sample BCH1031. Starting at 5 days postinoculation, cyto-
pathic effects were observed. Virus was not isolated from 
other SAFV-positive samples (data not shown).
We identiﬁ  ed 3 genetic lineages, SAFV-1, -2 and -3, 
on the basis of phylogenetic analysis of VP1, the most di-
verse protein of picornaviruses (6) (Figure 1). Multiple-
alignment analysis, based on reference sequences of each 
lineage available in GenBank, showed that the identity of 
the VP1 amino acid sequences among the strains in the 
same lineage was 92.6%–100% and among strains belong-
ing to different lineages, 63.3%–100% (online Appendix 
Table, www.cdc.gov/EID/content/16/7/1158-appT.htm). 
We found no obvious differences in amino acid sequences, 
nor any new motifs in these sequences, between strains 
detected in respiratory samples and those in fecal samples 
within the same lineage.
To further characterize the variation of SAFVs, we 
ampliﬁ  ed the P1 region sequences of 6 strains identiﬁ  ed in 
this study. The identity of all available nucleotide sequenc-
es of the P1 region among SAFVs was 68.5%–97.2%, 
whereas that of amino acid sequences was 74.9%–99.4%. 
The VP1 CD and VP2 EF loop structures, which display 
the greatest amino acid divergence among different SAFVs 
and are associated with tropism and virulence (6,7), were 
analyzed by amino acid alignment. Similar to previously 
reported ﬁ  ndings (6,7), we found that the sequences in both 
loops among SAFVs were highly diverse among SAFVs 
(Figure 2). The amino acid identities among all known 
SAFVs were 53.1%–100% in CD loops and 40.3%–100% 
in EF loops; amino acid identities of SAFVs versus animal 
cardioviruses were 29.1%–41.1% in CD loops and 19.2%–
32.6% in EF loops. We did not ﬁ  nd any major differences 
among the available amino acid sequences of CD loops 
(91.1%–100.0%) or EF loops (97.9%–100.0%) of SAFVs 
within the same lineage for samples collected from either 
the gastrointestinal or respiratory tracts.
The complete genome sequence of BCH1031 (SAFV-3) 
was obtained, as were nearly complete genome sequences 
of BCHU115 (SAFV-3) and BCHU79 (SAFV-2), which 
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Figure 2. Alignment of Saffold cardiovirus 
(SAFV) viral protein (VP) 1 CD (A) and VP2 
EF (B) loop sequences from strains isolated 
in Beijing, China, 2007–2009. Columns 
highlighted in black show absolute amino acid 
conservation; those highlighted in gray show 
amino acids with highly similar properties. 
Strains identiﬁ  ed in this study are labeled with 
dark triangles (BCH133, BCH1031, BCHU115, 
BCH350, BCH895, BCHU353 and BCHU79) 
(GenBank accession nos. GU126461, 
GU943513–GU943518), SAFV-1 (prototype), 
SAFV-1 GL317, SAFV-2 Can112051-
06, SAFV-2 BR/118/2006, SAFV-2 D/
VI/2229/2004, SAFV-2 Pak971, SAFV-2 UC1, 
SAFV-3 Pak2578, SAFV-3 D/VI/2223/2004, 
SAFV-3 D/VI/2273/2004, SAFV-3 NL2007, 
SAFV-4 Pak12, SAFV-5 Pak5152, SAFV-6 
Pak 6572, SAFV-7 Afg1449, SAFV-8 Pak1141, 
Theiler-like virus NGS910, TMEV GDVII, and 
EMCV were used as reference sequences 
(GenBank accession nos. NC009448, 
FJ464767, AM922293, EU681177, EU681176, 
FJ463601, NC010810, FJ463605, EU681179, 
EU681178, FM207487, FJ463600, FJ463616, 
FJ463617, FJ463602, FJ463604, AB090161, 
X56019, X87335).Saffold Cardioviruses in Children, China
covered full-length coding sequences as well as the 3′ UTR 
and a partial 5′ UTR (Figure 1). SimPlot analysis showed 
relatively high (>86%) identity between strains within the 
same lineage. No clear evidence of genetic recombination 
between the SAFV strains was found (online Appendix 
Figure, www.cdc.gov/EID/content/16/7/1158-appF.htm).
Conclusions
Although 8 lineages of SAFV have been detected in 
fecal samples worldwide, only SAFV-2 has been detected 
in respiratory samples (2,4). In addition, only SAFV-1 had 
been reported in China (5,13). In this study, we found that 
SAFV lineages 1, 2, and 3 co-circulated in patients with 
respiratory infections in Beijing.
Although SAFV is known to be transmitted by the 
fecal–oral route (1,3–7), as are other picornaviruses (14), 
our detection of SAFV in respiratory samples suggests that 
various SAFV lineages may also be transmitted through the 
respiratory tract and may be associated with disease. How-
ever, other respiratory viruses and M. pneumoniae were co-
detected in 3 of the 7 SAFV-positive patients. Given that 
we did not conduct assays for common respiratory bacte-
ria (and the number of SAFV-positive cases was limited), 
whether SAFV actually caused the observed symptoms in 
the patients cannot be deﬁ  nitively determined.
The genetic diversity of SAFVs in respiratory samples 
can complicate the relationship between SAFVs and dis-
ease because different genotypes of the same picornavirus 
species may cause different clinical signs and symptoms 
(6,14). Further investigations are needed to clarify any pos-
sible link between the pathogenicity and genetic diversity 
of SAFV.
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